Free Trial

VYNE Therapeutics (VYNE) Institutional Ownership

VYNE Therapeutics logo
$0.33 +0.00 (+1.01%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$0.33 0.00 (-0.15%)
As of 08/28/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for VYNE Therapeutics (NASDAQ:VYNE)

Current
Institutional Ownership
Percentage
83.78%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$7.58M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$1.27M
Get VYNE Insider Trade Alerts

Want to know when executives and insiders are buying or selling VYNE Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

VYNE Institutional Buying and Selling by Quarter

VYNE Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Exome Asset Management LLC208,970$345K0.2%-54.8%1.374%
8/15/2025 Boothbay Fund Management LLC106,459$176K0.0%N/A0.700%
8/15/2025 Acorn Capital Advisors LLC736,572$1.22M0.8%-6.3%4.843%
8/15/2025 Adage Capital Partners GP L.L.C.644,134$1.06M0.0%+87.2%4.235%
8/14/2025 Jane Street Group LLC124,822$206K0.0%N/A0.821%
8/14/2025 TFG Asset Management GP Ltd115,384$190K0.0%N/A0.759%
8/14/2025 Velan Capital Investment Management LP30,000$50K0.0%N/A0.197%
8/13/2025 Kennedy Capital Management LLC570,740$942K0.0%N/A3.752%
8/11/2025 Patient Square Capital LP317,033$523K0.2%+23.3%2.084%
5/19/2025 Acorn Capital Advisors LLC785,938$1.24M0.8%+72.0%5.167%
5/16/2025 Exome Asset Management LLC462,801$731K0.6%+30.9%3.043%
5/16/2025 Parkman Healthcare Partners LLC217,978$344K0.0%+42.5%1.433%
5/16/2025 Adage Capital Partners GP L.L.C.344,134$544K0.0%+123.3%2.263%
5/16/2025 ADAR1 Capital Management LLC70,419$111K0.0%N/A0.463%
5/15/2025 DAFNA Capital Management LLC636,103$1.01M0.3%N/A4.182%
5/12/2025 Virtu Financial LLC19,574$31K0.0%N/A0.129%
5/8/2025 XTX Topco Ltd33,052$52K0.0%+57.3%0.217%
2/17/2025 Parkman Healthcare Partners LLC152,973$512K0.1%-24.6%1.037%
2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC245,800$823K0.1%N/A1.666%
2/17/2025 Bridgeway Capital Management LLC36,958$124K0.0%N/A0.251%
2/17/2025 Acorn Capital Advisors LLC456,970$1.53M0.8%N/A3.098%
2/14/2025 Jane Street Group LLC20,286$68K0.0%N/A0.138%
2/14/2025 Schonfeld Strategic Advisors LLC176,658$592K0.0%+4.8%1.198%
2/14/2025 Northern Trust Corp23,971$80K0.0%-35.7%0.163%
2/14/2025 Adage Capital Partners GP L.L.C.154,134$516K0.0%N/A1.045%
2/13/2025 XTX Topco Ltd21,018$70K0.0%N/A0.142%
2/13/2025 Renaissance Technologies LLC24,943$84K0.0%-71.2%0.169%
11/15/2024 Parkman Healthcare Partners LLC202,973$382K0.0%-41.2%1.376%
10/30/2024AlphaCentric Advisors LLC268,485$505K0.4%-13.5%1.820%
8/15/2024 Lynx1 Capital Management LP16,194$32K0.0%N/A0.111%
8/9/2024 Renaissance Technologies LLC63,111$124K0.0%-21.7%0.434%
7/26/2024AlphaCentric Advisors LLC310,500$612K0.5%-30.2%2.137%
5/20/2024 Virtu Financial LLC16,199$50K0.0%N/A0.112%
2/20/2024 Eventide Asset Management LLC1,394,336$3.25M0.1%N/A9.988%
2/15/2024 Parkman Healthcare Partners LLC696,470$1.62M0.2%N/A4.990%
5/15/2023DSC Advisors L.P.115,000$354K0.3%-92.7%3.523%
5/10/2023 Staley Capital Advisers Inc.23,472$72K0.0%-62.4%0.720%
10/7/2022 Mackenzie Financial Corp134,920$30K0.0%+106.8%0.233%
4/25/2022 Bailard Inc.139,381$91K0.0%N/A0.248%
2/15/2022DSC Advisors L.P.2,551,000$2.60M2.0%+131.9%4.767%
This stock could leave NVDA in the dust (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
2/14/2022 Perceptive Advisors LLC2,178,022$2.22M0.0%-6.5%4.070%
2/14/2022 GSA Capital Partners LLP217,747$222K0.0%+135.7%0.407%
1/24/2022 SkyOak Wealth LLC27,200$28K0.0%N/A0.051%
12/3/2021 Perceptive Advisors LLC2,330,471$3.24M0.0%-59.6%4.355%
11/16/2021 Thrivent Financial for Lutherans71,990$101K0.0%+20.2%0.140%
11/15/2021 683 Capital Management LLC715,386$994K0.0%-2.5%1.389%
11/15/2021Healthcare Value Capital LLC400,000$556K1.1%-11.1%0.777%
11/15/2021 Franklin Resources Inc.1,921,236$2.67M0.0%+1.1%3.730%
11/15/2021 GSA Capital Partners LLP92,402$128K0.0%N/A0.179%
11/12/2021 Renaissance Technologies LLC1,245,027$1.73M0.0%+300.4%2.417%
11/5/2021 Staley Capital Advisers Inc.50,000$70K0.0%+33.3%0.097%
10/29/2021 Banque Cantonale Vaudoise80,000$111K0.0%-60.0%0.155%
10/13/2021 Deltec Asset Management LLC30,000$42K0.0%-92.2%0.058%
9/24/2021 Thrivent Financial for Lutherans59,884$211K0.0%N/A0.116%
8/19/2021 Thrivent Financial for Lutherans59,884$211K0.0%N/A0.116%
8/17/2021 Millennium Management LLC679,211$2.38M0.0%+2,513.0%1.322%
8/17/2021 Price T Rowe Associates Inc. MD40,050$141K0.0%+23.5%0.078%
8/17/2021 683 Capital Management LLC733,683$2.58M0.1%N/A1.428%
8/16/2021 LMR Partners LLP19,758$69K0.0%N/A0.038%
8/16/2021 Cubist Systematic Strategies LLC121,419$426K0.0%N/A0.236%
8/16/2021 Perceptive Advisors LLC5,773,954$20.27M0.2%-14.8%11.236%
8/16/2021 Charles Schwab Investment Management Inc.20,154$71K0.0%-79.6%0.039%
8/16/2021 State Street Corp534,613$1.88M0.0%-44.3%1.040%
8/16/2021Tibra Equities Europe Ltd91,000$319K0.1%N/A0.177%
8/13/2021 Renaissance Technologies LLC310,927$1.09M0.0%N/A0.605%
8/13/2021 Northern Trust Corp98,524$346K0.0%-74.9%0.192%
8/13/2021 Franklin Resources Inc.1,900,863$6.67M0.0%+12.5%3.699%
8/13/2021 AXA S.A.120,644$423K0.0%-86.3%0.235%
8/13/2021 Geode Capital Management LLC466,599$1.64M0.0%-36.0%0.908%
8/13/2021 Vanguard Group Inc.2,436,432$8.55M0.0%-2.1%4.741%
8/12/2021 JPMorgan Chase & Co.11,008$38K0.0%-85.9%0.021%
8/12/2021Ergoteles LLC158,800$557K0.0%N/A0.309%
8/12/2021 Connor Clark & Lunn Investment Management Ltd.60,186$211K0.0%N/A0.117%
8/11/2021 Bank of New York Mellon Corp26,626$94K0.0%-81.4%0.052%
8/11/2021BlackRock Inc.1,037,677$3.64M0.0%-71.2%2.019%
8/11/2021 Deutsche Bank AG48,234$169K0.0%+104.2%0.094%
8/11/2021 Banque Cantonale Vaudoise200,000$702K0.0%N/A0.389%
8/10/2021 Principal Financial Group Inc.11,849$42K0.0%N/A0.023%
8/9/2021 Staley Capital Advisers Inc.37,500$132K0.0%+50.0%0.073%
8/6/2021 HighTower Advisors LLC13,504$50K0.0%-44.3%0.026%
8/5/2021 Platform Technology Partners15,832$56K0.0%N/A0.031%
8/5/2021Fernwood Investment Management LLC10,802$38K0.0%-29.4%0.021%
5/18/2021 Millennium Management LLC25,994$178K0.0%N/A0.051%
(Data available from 1/1/2016 forward)

VYNE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VYNE shares?

During the previous two years, 22 institutional investors and hedge funds held shares of VYNE Therapeutics. The most heavily invested institutionals were Eventide Asset Management LLC ($3.25M), Acorn Capital Advisors LLC ($1.22M), Adage Capital Partners GP L.L.C. ($1.06M), DAFNA Capital Management LLC ($1.01M), Kennedy Capital Management LLC ($942K), OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC ($823K), and Schonfeld Strategic Advisors LLC ($592K).Learn more on VYNE Therapeutics' institutional investors.

What percentage of VYNE Therapeutics' stock is owned by institutional investors?

83.78% of VYNE Therapeutics' stock is owned by institutional investors. Learn more on VYNE's institutional investor holdings.

Which institutional investors have been buying VYNE Therapeutics' stock?

Of the 19 institutional investors that purchased VYNE Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($1.39M), Acorn Capital Advisors LLC ($785.94K), Parkman Healthcare Partners LLC ($761.48K), Adage Capital Partners GP L.L.C. ($644.13K), DAFNA Capital Management LLC ($636.10K), Kennedy Capital Management LLC ($570.74K), and OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC ($245.80K).

How much institutional buying is happening at VYNE Therapeutics?

Institutional investors have bought a total of 3,682,099 shares in the last 24 months. This purchase volume represents approximately $7.58M in transactions.

Which of VYNE Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold VYNE Therapeutics stock in the last 24 months: Exome Asset Management LLC ($253.83K), Parkman Healthcare Partners LLC ($192.23K), Renaissance Technologies LLC ($61.70K), Acorn Capital Advisors LLC ($49.37K), AlphaCentric Advisors LLC ($42.02K), and Northern Trust Corp ($13.32K).

How much institutional selling is happening at VYNE Therapeutics?

Institutional investors have sold a total of 612,464 shares in the last 24 months. This volume of shares sold represents approximately $1.27M in transactions.



This page (NASDAQ:VYNE) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners